Postpartum hemorrhage is the major killer of women in the developing world (one woman every four minutes dies this way). One of the key issues is the speed with which an anemic woman can lose her life if she is not provided life-saving care. Often women are lost in transit to a facility that could have provided the care. But what if you could ‘buy time’—stabilizing the woman until she reaches a higher level facility. This is the idea behind the NASG, a device that is a potential game changer for women’s survival. The NASG, also called the non-pneumatic anti-shock garment, is a medical device that externally wraps around a woman experiencing hemorrhage and ‘buys her time’--time to get to a higher level health facility with life-saving drugs and blood transfusion.Two key clinical studies of the LifeWrap device came out in late 2009—one from Nigeria and one from Egypt. Though much more could be written (and will be), to sum up, maternal mortality and morbidity was lower with the use of the NASG. The authors report that in both studies “the measured blood loss was significantly lower for women treated with the NASG: 78% lower in Nigeria and 50% lower in Egypt.” The study also found that uterine atony (failure of the uterus to contract)—and a major cause of postpartum hemorrhage—was the cause of hemorrhage in only 30% of the cases studied. The more that is understood about the reasons for postpartum hemorrhage the better.

Leave a comment

Comments will be approved before showing up.


Also in The Maternova Blog

Benefits of intravenous iron to treat anemia in pregnancy
Benefits of intravenous iron to treat anemia in pregnancy

March 19, 2024 5 min read

Read More
A Point of Care Bilirubinometer Using Blood: BiliDx
A Point of Care Bilirubinometer Using Blood: BiliDx

January 16, 2024 2 min read

The BiliDx is a novel system for diagnosing jaundice.  The device uniquely meets the Target Product Profile (TPP) developed as part of the NEST 360 initiative in that it allows blood-based testing at the bedside.   This initiative is part of an emerging global consensus in the Every Newborn Action Plan that countries need functional WHO level-2 inpatient units to care for "small and sick newborns." 
Read More
NASG as a life-saving medical device to stabilize women with postpartum hemorrhage
Clinical Indications for Applying (and Removing) the NASG: Rule of 20

January 15, 2024 2 min read

The garment must be removed upon reaching hemodynamic stability for at least two hours, where it is evident:

  • Blood loss less than 50 mL/hour
  • Pulse less than 100 beats per minute
Read More